Frank E Thomas
Officer at Orchard Therapeutics plc (ORTX)
Frank E Thomas has filed 23 insider reports with the SEC since February 2021, as director at Spero Therapeutics, Inc. (SPRO), director at Larimar Therapeutics, Inc. (LRMR) and officer at Orchard Therapeutics plc (ORTX). In the last 12 months Frank E Thomas bought $25K of stock on the open market. The latest filing, on June 25, 2026, reports grant or award at Spero Therapeutics, Inc. (SPRO).
- Filings
- 23
- Companies
- 3
- Bought on market
- $54.5K
- Sold on market
- None
Companies where Frank E Thomas is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 85,000 | $1.01 | Jun 25, 2026 | ||||
| Director | 7,000 | $47K | $6.71 | $2.69-60% | May 20, 2026 | ||
| Officer | 0 | $7,474 | $0.75 | Jan 24, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 23, 2026SPRODirector Thomas Frank E was granted 10,000 shares, increasing direct ownership by 13% to 85,000 unitsForm 4Grant or award
- May 19, 2026LRMRSEC Form 4 filed by Director Thomas Frank EForm 4Grant or award
- Feb 27, 2026+$25KLRMRDirector Thomas Frank E bought $25,000 worth of shares (5,000 units at $5.00), increasing direct ownership by 250% to 7,000 unitsForm 4/AOpen-market purchase
- Jun 12, 2025SPRODirector Thomas Frank E was granted 20,000 shares, increasing direct ownership by 36% to 75,000 unitsForm 4Grant or award
- May 13, 2025LRMRSEC Form 4 filed by Director Thomas Frank EForm 4Grant or award
- May 29, 2024LRMRSEC Form 4 filed by Thomas Frank EForm 4Grant or award
- May 29, 2024SPROThomas Frank E was granted 20,000 shares, increasing direct ownership by 57% to 55,000 unitsForm 4Grant or award
- Feb 14, 2024+$22KLRMRThomas Frank E bought $22,000 worth of shares (2,000 units at $11.00)Form 4/AOpen-market purchase
- Jan 24, 2024ORTXThomas Frank E returned 92,081 units of Ordinary Shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- Oct 5, 2023SPROThomas Frank E was granted 20,000 shares, increasing direct ownership by 133% to 35,000 unitsForm 4Grant or award
- May 9, 2023LRMRSEC Form 4 filed by Thomas Frank EForm 4Grant or award
- Mar 10, 2023ORTXSEC Form 4: Thomas Frank E exercised 20,000 units of Ordinary Shares at a strike of $0.46, increasing direct ownership by 28% to 92,081 unitsForm 4Exercise or conversion of a derivative
- Feb 9, 2023ORTXSEC Form 4: Thomas Frank E exercised 20,000 units of Ordinary Shares at a strike of $0.46, increasing direct ownership by 38% to 72,081 unitsForm 4Exercise or conversion of a derivative
- Oct 4, 2022ORTXSEC Form 4 filed by Thomas Frank EForm 4Grant or awardSale back to the company
- Sep 15, 2022SPROSEC Form 4: Thomas Frank E was granted 15,000 sharesForm 4Grant or award
- Jun 1, 2022ORTXSEC Form 4 filed by Thomas Frank EForm 4Grant or award
- May 10, 2022LRMRSEC Form 4 filed by Thomas Frank EForm 4Grant or award
- Apr 1, 2022+$7,474ORTXSEC Form 4: Thomas Frank E bought $7,474 worth of Ordinary Shares (10,000 units at $0.75), increasing direct ownership by 24% to 52,081 unitsForm 4Open-market purchase
- Jan 5, 2022SPROSEC Form 4 filed by Thomas Frank EForm 4Grant or award
- Aug 17, 2021SPROSEC Form 4 filed by THOMAS FRANK EForm 4Grant or award
- May 12, 2021LRMRSEC Form 4 filed by THOMAS FRANK EForm 4Grant or award
- Feb 1, 2021ORTXSEC Form 4 filed by E Frank ThomasForm 4Grant or award
- Jan 29, 2021ORTXSEC Form 4: E Frank Thomas exercised 10,000 units of Ordinary Shares at a strike of $2.44, increasing ownership by 31% to 42,081 unitsForm 4Exercise or conversion of a derivative
Compare Frank E Thomas with
- Frank E Thomas vs Esther Rajavelu1 shared
- Frank E Thomas vs William Ho1 shared
- Frank E Thomas vs John B. Harlow Jr.1 shared
- Frank E Thomas vs Debra Zack1 shared
- Frank E Thomas vs Thomas Edward Hamilton1 shared
- Frank E Thomas vs Milind Deshpande1 shared
Other insiders at the same companies
- Esther RajaveluSPRO
- William HoSPRO
- John B. Harlow Jr.LRMR
- Debra ZackSPRO
- Thomas Edward HamiltonLRMR
- Milind DeshpandeSPRO
- Kathleen TregoningSPRO
- Cynthia SmithSPRO
- Patrick V.j.j. VinkSPRO
- Scott Thomas JacksonSPRO
- John C Pottage JrSPRO
- James E FlynnLRMR
- Jonathan S LeffLRMR
- Jeffrey W ShermanLRMR
- Joseph TruittLRMR
- Timothy KeutzerSPRO
Questions about Frank E Thomas
- What is Frank E Thomas's role at Orchard Therapeutics plc?
- Frank E Thomas reports to the SEC as officer at Orchard Therapeutics plc (ORTX), according to the latest filing on January 24, 2024. Frank E Thomas has also filed as director at Spero Therapeutics, Inc. (SPRO) and director at Larimar Therapeutics, Inc. (LRMR).
- How many shares does Frank E Thomas own?
- After the latest filing that states it, Frank E Thomas directly owned 85,000 shares of Spero Therapeutics, Inc. (SPRO) and 7,000 shares of Larimar Therapeutics, Inc. (LRMR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Frank E Thomas bought or sold stock recently?
- The most recent open-market purchase was on February 27, 2026: bought 5,000 shares of Larimar Therapeutics, Inc. (LRMR) for $25K at an average of $5.00.
- How do I get alerts when Frank E Thomas files?
- Follow Frank E Thomas on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Frank E Thomas (SEC CIK 0001242616). Totals count each trade once, skipping amendments whose original is on file, from Feb 1, 2021 on. View on SEC EDGAR